查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1645710

全球同位素市場（按類型和應用）- 機會分析和產業預測，2024 年至 2033 年

Isotopes Market By Type (Stable, Unstable), By Application (Medical, Industrial, Agricultural, Others): Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 259 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023 年全球同位素市場價值為 113 億美元，預計 2033 年將達到 258 億美元，2024 年至 2033 年的複合年成長率為 8.7%。

同位素分為穩定同位素和放射性同位素（不穩定）。穩定同位素不會隨時間而變化，也不具有放射性，但放射性同位素（放射性核種）會隨時間而崩壞變成其他元素，並在此過程中釋放輻射。同位素的穩定性和放射性影響醫學、工業和研究等各領域的應用。放射性同位素用於多種診斷成像技術。例如，Technetium-99m具有理想的成像特性，包括較短的半衰期和它發射的伽馬射線，因此它被廣泛用於單光子發射電腦斷層掃描（SPECT）。這種同位素可以使器官、骨骼和其他組織可見，並有助於診斷癌症、心臟病、骨骼疾病等。

同位素市場-IMG1

放射性同位素在治療中發揮重要作用。例如，碘-131用於治療甲狀腺癌和甲狀腺功能亢進。這種同位素針對甲狀腺細胞並發出輻射，破壞癌細胞並減緩甲狀腺功能亢進。同樣，鍶-89和釤-153可透過針對骨病變來治療與轉移性癌症相關的骨痛。在癌症治療中，鈷-60等放射性同位素用於外部放射治療。鈷-60發射的伽馬射線可以穿透人體並殺死癌細胞，同時最大限度地減少對周圍健康組織的傷害。

在工業X光攝影中，銥-192和鈷-60等同位素用於檢查結構和零件的完整性。這些同位素會發射伽馬射線，能夠穿透材料。所得到的圖像可以揭示裂縫和腐蝕等內部缺陷，對於確保管道和焊接等結構的安全性和可靠性至關重要。同位素在工業製程的研究中扮演示蹤劑的角色。例如，碳-14和氘（氫的穩定同位素）用於追蹤化學反應和過程，使科學家能夠研究反應機制、流動模式和物質分佈。這有助於最佳化石化和製藥等行業的流程。

同位素對於研究水源和遷移很有用。例如，氚（氫的放射性同位素）可用於追蹤地下水運動並評估水的年齡。氫和氧的穩定同位素也用於分析水體的來源和路徑，這對於水資源管理和污染調查很有用。碳-13和氮-15等穩定同位素用於研究生物系統中的代謝過程、食物網和營養循環。同位素標記有助於追蹤元素在生物體和生態系統中的運動，提供有關生物功能和相互作用的寶貴資訊。

同位素市場分為類型、最終用途產業和地區。根據類型，市場分為穩定市場和波動市場。根據應用，市場分為醫療、工業、農業和其他。根據地區，市場分為北美、歐洲、亞太、拉丁美洲和中東及非洲。

按類型分類，不穩定同位素成長最快，預測期內複合年成長率為 9.0%。不穩定同位素，又稱為放射性同位素或放射性同位素，儘管本身俱有不穩定性，但在許多行業中卻有著多樣化且重要的應用。在醫學上，不穩定同位素對於診斷影像和治療至關重要。例如，Technetium-99m是一種伽馬射線發射同位素，由於其能夠突出顯示生理過程，被廣泛用於核醫學的骨骼、器官和組織的診斷成像。放射性碘（I-131）還可以選擇性地靶向甲狀腺細胞，因此被廣泛用於治療甲狀腺疾病，包括甲狀腺功能亢進和某些類型的癌症。此外，氟-18等正子發射同位素可用於正子斷層掃描 (PET) 掃描，以觀察組織中的代謝活動，有助於癌症等疾病的早期診斷。

從地區來看，亞太地區佔據市場主導地位，預測期內成長最快，複合年成長率為 9.0%。在亞太地區，同位素廣泛應用於各種應用、產品和產業，對醫療、工業、農業和環境部門產生重大影響。在醫學領域，Technetium-99m等同位素在日本、韓國、中國等國家被廣泛應用於診斷影像和癌症治療。放射治療、核子醫學攝影和 PET 掃描是受益於這些同位素的基本醫療服務，有助於高精度地識別、監測和治療病情。碘-131和鈷-60是癌症治療和放射療法中常用的其他同位素，使亞太地區的醫院和醫療中心能夠提供更先進的醫療干預。

預計預測期內核醫學技術的創新將推動同位素市場的成長。核子醫學的進步透過放射性藥物和成像技術的創新刺激了對專用同位素的需求。在該領域，放射性同位素用於診斷和治療疾病，PET、SPECT等影像診斷方法是關鍵。最近的趨勢導致了更有效的放射性藥物的開發。 2022 年 2 月，核子醫學和分子影像學會 (SNMMI) 發起了舉措，將核子醫學設施認定為放射性藥物治療卓越中心 (COE)。該計劃對法規遵從性、員工培訓、資格和績效設定了高標準，以確保接受放射性藥物治療的患者獲得最佳結果。

預計預測期內原料供應有限將成長抑制因素。同位素生產所需原料的可用性是同位素市場的一個主要限制因素。許多同位素是由稀有或低豐度原料生產的，而這些原料的供應可能有限。這種稀缺性可能導致生產同位素和使用它們的最終產品的成本更高。例如，醫學影像和工業應用中使用的某些同位素來自於不廣泛存在的特定元素或礦物。

相關人員的主要利益

  • 本報告定量分析了市場區隔、當前趨勢、估計和趨勢分析、2023 年至 2033 年同位素市場分析的動態，並確定了同位素市場的突出機會。
  • 它為市場研究提供與市場促進因素、市場限制因素和市場機會相關的資訊。
  • 波特五力分析揭示了買家和供應商的潛力，幫助相關人員做出利潤驅動的商業決策，並加強供應商-買家網路。
  • 對同位素市場細分的詳細分析有助於確定市場機會。
  • 每個地區的主要國家都根據收益貢獻進行分類。
  • 市場公司的定位有利於進行對標，並能清楚了解市場公司的當前地位。
  • 報告包括區域和全球同位素半導體市場趨勢、主要企業、細分市場、應用領域和市場成長策略的分析。

此報告可進行客製化（需支付額外費用和時間表）

  • 產品成分分析（%）
  • 最終用戶的偏好和痛點
  • 投資機會
  • 新參與企業（按地區）
  • 科技趨勢分析
  • 按產品/細分市場對參與者進行市場區隔分析
  • 主要公司的新產品開發/產品矩陣
  • 國家、地區和全球層面的患者/流行病學資料
  • 根據客戶興趣提供額外的公司簡介
  • 按國家或地區進行的額外分析 - 市場規模和預測
  • 歷史市場資料
  • Excel 格式的主要企業詳細資料（包括位置、聯絡資訊、供應商/供應商網路等）
  • 客戶/消費者/原料供應商名單－價值鏈分析
  • SWOT 分析
  • 量化市場規模及預測

目錄

第 1 章 簡介

第 2 章執行摘要

第3章 市場概況

  • 市場定義和範圍
  • 主要發現
    • 關鍵影響因素
    • 重大投資機會
  • 波特五力分析
  • 市場動態
    • 驅動程式
      • 核子醫學技術創新
      • 工業 X光成像需求不斷成長
    • 限制因素
      • 同位素生產成本上升
    • 機會
      • 診斷影像需求不斷成長
  • 專利分析

第 4 章 同位素市場類型

  • 概述
  • 穩定
  • 不穩定

第 5 章 同位素市場（依應用）

  • 概述
  • 醫療的
  • 工業的
  • 農業
  • 其他

6. 同位素市場（按地區）

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 其他
  • 拉丁美洲、中東和非洲
    • 巴西
    • 南非
    • 沙烏地阿拉伯
    • 其他

第7章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 前 10 家公司的產品圖譜
  • 競爭儀錶板
  • 競爭熱圖
  • 2023年主要企業的定位

第8章 公司簡介

  • 3M
  • Isotope JSC
  • Cambridge Isotope Laboratories, Inc.
  • Center of Molecular Research（CMR）
  • Urenco
  • Linde PLC
  • Marshall Isotopes Ltd.
  • Eckert & Ziegler
  • Laurentis Energy Partners Inc.
  • Nordion（Canada）Inc.
簡介目錄
Product Code: A123022

The global isotopes market was valued at $11.3 billion in 2023, and is projected to reach $25.8 billion by 2033, growing at a CAGR of 8.7% from 2024 to 2033.

Isotopes can be classified into stable and radioactive (unstable) isotopes. Stable isotopes do not change over time and are not radioactive, while radioactive isotopes, or radionuclides, decay over time into other elements, emitting radiation in the process. The stability or radioactivity of an isotope influences its application in various fields, including medicine, industry, and research. Radioactive isotopes are used in various imaging techniques. For instance, Technetium-99m is widely used in single photon emission computed tomography (SPECT) scans due to its ideal properties for imaging, such as its short half-life and the gamma rays it emits. This isotope helps in visualizing organs, bones, and other tissues, aiding in the diagnosis of conditions like cancer, heart disease, and bone disorders.

Isotopes Market - IMG1

Radioisotopes play a important role in the medical treatment. For instance, Iodine-131 is used in the treatment of thyroid cancer and hyperthyroidism. This isotope targets thyroid cells and emits radiation to destroy cancerous cells or reduce the function of an overactive thyroid. Similarly, strontium-89 and samarium-153 are used to treat bone pain associated with metastatic cancer by targeting bone lesions. In cancer treatment, radioactive isotopes such as cobalt-60 are used in external beam radiotherapy. Cobalt-60 emits gamma rays that can penetrate the body and kill cancer cells, while minimizing damage to surrounding healthy tissue.

In industrial radiography, isotopes like iridium-192 and cobalt-60 are used to inspect the integrity of structures and components. These isotopes emit gamma rays that pass through materials, and the resulting images reveal internal flaws such as cracks or corrosion, which are crucial for ensuring the safety and reliability of structures like pipelines and welds. Isotopes serve as tracers in studies of industrial processes. For instance, Carbon-14 and deuterium (a stable isotope of hydrogen) are used to trace chemical reactions and processes, allowing scientists to study reaction mechanisms, flow patterns, and material distribution. This helps optimize processes in industries such as petrochemicals and pharmaceuticals.

Isotopes help in studying water sources and movement. For example, tritium (a radioactive isotope of hydrogen) is used to trace groundwater movement and assess water age. Stable isotopes of hydrogen and oxygen are also used to analyze the origins and pathways of water bodies, aiding in water resource management and pollution studies. Stable isotopes such as carbon-13 and nitrogen-15 are used to study metabolic processes, food webs, and nutrient cycling in biological systems. Isotopic labeling helps trace the movement of elements through organisms and ecosystems, providing valuable information on biological functions and interactions

The isotopes market is segmented into type, end-use industry, and region. On the basis of type, the market is classified into stable and unstable. On the basis of application, the market is classified into medical, industrial, agricultural, and others. Based on region the market is divided into North America, Europe, Asia-Pacific, and LAMEA.

On the basis of type, unstable is the fastest-growing segment in the market representing the CAGR of 9.0% during the forecast period. Unstable isotopes, also known as radioactive isotopes or radioisotopes, have diverse and critical applications across numerous industries, despite their inherent instability. In the medical field, unstable isotopes are essential for diagnostic imaging and treatment. For example, technetium-99m, a gamma-emitting isotope, is widely used in nuclear medicine for imaging bones, organs, and tissues due to its ability to highlight physiological processes. Radioactive iodine (I-131) is also extensively used to treat thyroid conditions, including hyperthyroidism and certain types of cancer, as it can selectively target thyroid cells. Additionally, positron-emitting isotopes like fluorine-18 are used in positron emission tomography (PET) scans to visualize metabolic activity in tissues, aiding in early diagnosis of diseases such as cancer.

Based on region Asia-Pacific dominated and fastest growing segment in the market representing the CAGR of 9.0% during the forecast period. In the Asia-Pacific region, isotopes are widely used across various applications, products, and industries, significantly impacting medical, industrial, agricultural, and environmental sectors. In the medical field, isotopes like Technetium-99m are heavily utilized for diagnostic imaging and cancer treatment in countries such as Japan, South Korea, and China. Radiotherapy, nuclear imaging, and PET scans are critical healthcare services that benefit from these isotopes, helping identify, monitor, and treat conditions with high precision. Iodine-131 and Cobalt-60 are other common isotopes used in cancer treatments and radiotherapy, enabling hospitals and medical centers across Asia-Pacific to offer more advanced medical interventions.

Innovations in nuclear medicine technologies are expected to drive the growth of the isotopes market during the forecast period. Advancements in nuclear medicine have spurred demand for specialized isotopes due to innovations in radiopharmaceuticals and imaging technologies. This field uses radioactive isotopes for diagnosing and treating diseases, with imaging methods like PET and SPECT being key. Recent breakthroughs have led to the development of more effective radiopharmaceuticals. In February 2022, the society of nuclear medicine and molecular Imaging (SNMMI) launched an initiative to certify nuclear medicine facilities as Centers of Excellence in Radiopharmaceutical Therapy. This program sets high standards for regulatory compliance, staff training, qualifications, and performance to ensure the best outcomes for patients undergoing radiopharmaceutical therapy.

Limited availability of raw materials is expected to restraint the growth of the isotopes market during the forecast period. The availability of raw materials required for isotope production is a significant constraint in the isotopes market. Many isotopes are produced from rare or less abundant materials, and the supply of these raw materials can be limited. This scarcity can lead to increased costs for both the production of isotopes and the end products that utilize them. For example, certain isotopes used in medical imaging or industrial applications are derived from specific elements or minerals that are not widely distributed.

The key players operating in the isotopes market include 3M, Isotope JSC, Cambridge Isotope Laboratories, Inc, Center of Molecular Research (CMR), Urenco, National High Technology Centre of Georgia, Linde plc, Marshall Isotopes Ltd, Eckert & Ziegler, and Laurentis Energy Partners Inc.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the isotopes market analysis from 2023 to 2033 to identify the prevailing isotopes market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the isotopes market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global isotopes market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Analysis of raw material in a product (by %)
  • End user preferences and pain points
  • Investment Opportunities
  • Upcoming/New Entrant by Regions
  • Technology Trend Analysis
  • Market share analysis of players by products/segments
  • New Product Development/ Product Matrix of Key Players
  • Patient/epidemiology data at country, region, global level
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)
  • List of customers/consumers/raw material suppliers- value chain analysis
  • SWOT Analysis
  • Volume Market Size and Forecast

Key Market Segments

By Type

  • Stable
  • Unstable

By Application

  • Others
  • Medical
  • Industrial
  • Agricultural

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • 3M
    • Cambridge Isotope Laboratories, Inc.
    • Center of Molecular Research (CMR)
    • Eckert & Ziegler
    • Isotope JSC
    • Laurentis Energy Partners Inc.
    • Linde PLC
    • Marshall Isotopes Ltd.
    • Nordion (Canada) Inc.
    • Urenco

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Moderate bargaining power of suppliers
    • 3.3.2. Moderate threat of new entrants
    • 3.3.3. Moderatre threat of substitutes
    • 3.3.4. Moderate intensity of rivalry
    • 3.3.5. Moderate bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Innovations in nuclear medicine technologies
      • 3.4.1.2. Increase in demand for industrial radiography
    • 3.4.2. Restraints
      • 3.4.2.1. High production costs of isotopes
    • 3.4.3. Opportunities
      • 3.4.3.1. Increase in demand for diagnostic imaging
  • 3.5. Patent Analysis

CHAPTER 4: ISOTOPES MARKET, BY TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Stable
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Unstable
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: ISOTOPES MARKET, BY APPLICATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Medical
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Industrial
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Agricultural
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Others
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country

CHAPTER 6: ISOTOPES MARKET, BY REGION

  • 6.1. Overview
    • 6.1.1. Market size and forecast By Region
  • 6.2. North America
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by Type
    • 6.2.3. Market size and forecast, by Application
    • 6.2.4. Market size and forecast, by country
      • 6.2.4.1. U.S.
      • 6.2.4.1.1. Market size and forecast, by Type
      • 6.2.4.1.2. Market size and forecast, by Application
      • 6.2.4.2. Canada
      • 6.2.4.2.1. Market size and forecast, by Type
      • 6.2.4.2.2. Market size and forecast, by Application
      • 6.2.4.3. Mexico
      • 6.2.4.3.1. Market size and forecast, by Type
      • 6.2.4.3.2. Market size and forecast, by Application
  • 6.3. Europe
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by Type
    • 6.3.3. Market size and forecast, by Application
    • 6.3.4. Market size and forecast, by country
      • 6.3.4.1. Germany
      • 6.3.4.1.1. Market size and forecast, by Type
      • 6.3.4.1.2. Market size and forecast, by Application
      • 6.3.4.2. France
      • 6.3.4.2.1. Market size and forecast, by Type
      • 6.3.4.2.2. Market size and forecast, by Application
      • 6.3.4.3. UK
      • 6.3.4.3.1. Market size and forecast, by Type
      • 6.3.4.3.2. Market size and forecast, by Application
      • 6.3.4.4. Spain
      • 6.3.4.4.1. Market size and forecast, by Type
      • 6.3.4.4.2. Market size and forecast, by Application
      • 6.3.4.5. Italy
      • 6.3.4.5.1. Market size and forecast, by Type
      • 6.3.4.5.2. Market size and forecast, by Application
      • 6.3.4.6. Rest of Europe
      • 6.3.4.6.1. Market size and forecast, by Type
      • 6.3.4.6.2. Market size and forecast, by Application
  • 6.4. Asia-Pacific
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by Type
    • 6.4.3. Market size and forecast, by Application
    • 6.4.4. Market size and forecast, by country
      • 6.4.4.1. China
      • 6.4.4.1.1. Market size and forecast, by Type
      • 6.4.4.1.2. Market size and forecast, by Application
      • 6.4.4.2. India
      • 6.4.4.2.1. Market size and forecast, by Type
      • 6.4.4.2.2. Market size and forecast, by Application
      • 6.4.4.3. Japan
      • 6.4.4.3.1. Market size and forecast, by Type
      • 6.4.4.3.2. Market size and forecast, by Application
      • 6.4.4.4. South Korea
      • 6.4.4.4.1. Market size and forecast, by Type
      • 6.4.4.4.2. Market size and forecast, by Application
      • 6.4.4.5. Australia
      • 6.4.4.5.1. Market size and forecast, by Type
      • 6.4.4.5.2. Market size and forecast, by Application
      • 6.4.4.6. Rest of Asia-Pacific
      • 6.4.4.6.1. Market size and forecast, by Type
      • 6.4.4.6.2. Market size and forecast, by Application
  • 6.5. LAMEA
    • 6.5.1. Key market trends, growth factors and opportunities
    • 6.5.2. Market size and forecast, by Type
    • 6.5.3. Market size and forecast, by Application
    • 6.5.4. Market size and forecast, by country
      • 6.5.4.1. Brazil
      • 6.5.4.1.1. Market size and forecast, by Type
      • 6.5.4.1.2. Market size and forecast, by Application
      • 6.5.4.2. South Africa
      • 6.5.4.2.1. Market size and forecast, by Type
      • 6.5.4.2.2. Market size and forecast, by Application
      • 6.5.4.3. Saudi Arabia
      • 6.5.4.3.1. Market size and forecast, by Type
      • 6.5.4.3.2. Market size and forecast, by Application
      • 6.5.4.4. Rest of LAMEA
      • 6.5.4.4.1. Market size and forecast, by Type
      • 6.5.4.4.2. Market size and forecast, by Application

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top winning strategies
  • 7.3. Product mapping of top 10 player
  • 7.4. Competitive dashboard
  • 7.5. Competitive heatmap
  • 7.6. Top player positioning, 2023

CHAPTER 8: COMPANY PROFILES

  • 8.1. 3M
    • 8.1.1. Company overview
    • 8.1.2. Key executives
    • 8.1.3. Company snapshot
    • 8.1.4. Operating business segments
    • 8.1.5. Product portfolio
    • 8.1.6. Business performance
  • 8.2. Isotope JSC
    • 8.2.1. Company overview
    • 8.2.2. Key executives
    • 8.2.3. Company snapshot
    • 8.2.4. Operating business segments
    • 8.2.5. Product portfolio
  • 8.3. Cambridge Isotope Laboratories, Inc.
    • 8.3.1. Company overview
    • 8.3.2. Key executives
    • 8.3.3. Company snapshot
    • 8.3.4. Operating business segments
    • 8.3.5. Product portfolio
  • 8.4. Center of Molecular Research (CMR)
    • 8.4.1. Company overview
    • 8.4.2. Key executives
    • 8.4.3. Company snapshot
    • 8.4.4. Operating business segments
    • 8.4.5. Product portfolio
  • 8.5. Urenco
    • 8.5.1. Company overview
    • 8.5.2. Key executives
    • 8.5.3. Company snapshot
    • 8.5.4. Operating business segments
    • 8.5.5. Product portfolio
    • 8.5.6. Business performance
    • 8.5.7. Key strategic moves and developments
  • 8.6. Linde PLC
    • 8.6.1. Company overview
    • 8.6.2. Key executives
    • 8.6.3. Company snapshot
    • 8.6.4. Operating business segments
    • 8.6.5. Product portfolio
    • 8.6.6. Business performance
  • 8.7. Marshall Isotopes Ltd.
    • 8.7.1. Company overview
    • 8.7.2. Key executives
    • 8.7.3. Company snapshot
    • 8.7.4. Operating business segments
    • 8.7.5. Product portfolio
  • 8.8. Eckert & Ziegler
    • 8.8.1. Company overview
    • 8.8.2. Key executives
    • 8.8.3. Company snapshot
    • 8.8.4. Operating business segments
    • 8.8.5. Product portfolio
    • 8.8.6. Business performance
  • 8.9. Laurentis Energy Partners Inc.
    • 8.9.1. Company overview
    • 8.9.2. Key executives
    • 8.9.3. Company snapshot
    • 8.9.4. Operating business segments
    • 8.9.5. Product portfolio
  • 8.10. Nordion (Canada) Inc.
    • 8.10.1. Company overview
    • 8.10.2. Key executives
    • 8.10.3. Company snapshot
    • 8.10.4. Operating business segments
    • 8.10.5. Product portfolio